| Pancreatic cancer JD Mizrahi, R Surana, JW Valle, RT Shroff The Lancet 395 (10242), 2008-2020, 2020 | 1866 | 2020 |
| Monoclonal antibodies: versatile platforms for cancer immunotherapy LM Weiner, R Surana, S Wang Nature Reviews Immunology 10 (5), 317-327, 2010 | 1554 | 2010 |
| Monoclonal antibodies for the treatment of cancer CW Shuptrine, R Surana, LM Weiner Seminars in cancer biology 22 (1), 3-13, 2012 | 212 | 2012 |
| Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2 EF Zhu, SA Gai, CF Opel, BH Kwan, R Surana, MC Mihm, MJ Kauke, ... Cancer cell 27 (4), 489-501, 2015 | 206 | 2015 |
| Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma S Murakami, D Shahbazian, R Surana, W Zhang, H Chen, GT Graham, ... Oncogene 36 (9), 1232-1244, 2017 | 194 | 2017 |
| Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung JJ Osterholzer, R Surana, JE Milam, GT Montano, GH Chen, J Sonstein, ... The American journal of pathology 174 (3), 932-943, 2009 | 169 | 2009 |
| Antibodies and cancer therapy: versatile platforms for cancer immunotherapy LM Weiner, R Surana, S Wang Nature reviews. Immunology 10 (5), 317, 2010 | 38 | 2010 |
| Vaccine prevention of cancer: can endogenous antigens be targeted? LM Weiner, R Surana, J Murray Cancer Prevention Research 3 (4), 410-415, 2010 | 33 | 2010 |
| Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice M Miyaji, RL Kortum, R Surana, W Li, KD Woolard, RM Simpson, ... Proceedings of the National Academy of Sciences 106 (34), 14502-14507, 2009 | 32 | 2009 |
| Bam32: a novel mediator of Erk activation in T cells CL Sommers, JM Gurson, R Surana, M Barda-Saad, J Lee, A Kishor, ... International immunology 20 (7), 811-818, 2008 | 26 | 2008 |
| Effect of Laparotomy on Clearance and Cytokine Induction in Staphylococcus aureus–infected Lungs MA Olszewski, NR Falkowski, R Surana, J Sonstein, A Hartman, ... American journal of respiratory and critical care medicine 176 (9), 921-929, 2007 | 23 | 2007 |
| Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation. R Surana, VS LeBleu, JJ Lee, BG Smaglo, D Zhao, MS Lee, RA Wolff, ... Journal of Clinical Oncology 40 (4_suppl), TPS633-TPS633, 2022 | 16 | 2022 |
| IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model R Surana, S Wang, W Xu, SA Jablonski, LM Weiner Cancer immunology research 2 (11), 1103-1112, 2014 | 16 | 2014 |
| Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer H Singh, RB Keller, KS Kapner, J Dilly, S Raghavan, C Yuan, EF Cohen, ... Clinical Cancer Research 29 (22), 4627-4643, 2023 | 15 | 2023 |
| Phase II study of ipilimumab in men with metastatic prostate cancer with an incomplete response to androgen deprivation therapy JN Graff, MN Stein, R Surana, L Al Rabadi, E Liu, L Fong, S Bailey, ... Frontiers in Oncology 10, 1381, 2020 | 15 | 2020 |
| Emerging role of targeted therapy in metastatic pancreatic adenocarcinoma BM Huffman, H Ellis, AC Jordan, WA Freed-Pastor, K Perez, DA Rubinson, ... Cancers 14 (24), 6223, 2022 | 12 | 2022 |
| Phase I study of hydroxychloroquine plus binimetinib in patients with metastatic pancreatic cancer (the HOPE trial). R Surana, JJ Lee, BG Smaglo, D Zhao, MS Lee, RA Wolff, MJ Overman, ... Journal of Clinical Oncology 40 (4_suppl), TPS634-TPS634, 2022 | 4 | 2022 |
| Immunotherapy in gastrointestinal malignancies R Surana, S Pant Immunotherapy, 259-272, 2021 | 3 | 2021 |
| A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors. BL Schlechter, EE Dumbrava, MA George, S Saibil, MO Butler, ... Journal of Clinical Oncology 42 (3_suppl), 747-747, 2024 | 2 | 2024 |
| RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack YW Zhang, RE Nasto, SA Jablonski, IG Serebriiskii, R Surana, J Murray, ... Methods in enzymology 636, 299-322, 2020 | 2 | 2020 |
